Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1978-10-25
|
pubmed:abstractText |
Antisera were raised in New Zealand White rabbits against non-B, non-T acute lymphocytic leukemia (ALL) cells coated with antilymphocyte serum. Following minimal absorption with chronic lymphocytic leukemia (CLL) cells, the antiserum reacted mainly with non-B, non-T ALL cells. The following numbers of patients had leukemia cells that reacted with the ALL antisera: 13 of 18 with ALL, 3 of 27 with acute myelocytic leukemia, 1 of 8 with chronic myelocytic leukemia (CML), and 0 of 12 with CLL. The positive CML was a patient in CML blast crisis. Normal peripheral blood B- and T-lymphocytes and normal bone marrow were negative. Reactions of the anti-ALL serum (136K) were compared with the reactions of a rabbit anti-B-cell antiserum (63K) that reacted with approximately 70% of leukemia cells. Cultured lymphoblastoid cell lines from normal donors were negative by both cytotoxicity and immunofluorescence tests. However, by immunofluorescence testing, 8 of 17 known malignant lines from a variety of lymphoproliferative disorders were positive; 4 of these lines were of T-cell origin. By immunoprecipitation and polyacrylamide gel electrophoresis, the ALL antigen appeared to consist of a single polypeptide chain of approximately 98,000 daltons. The anti-ALL antiserum was not cytotoxic for normal myeloid stem cells (colony-forming units).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0027-8874
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
423-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:308102-Adult,
pubmed-meshheading:308102-Animals,
pubmed-meshheading:308102-Antibodies, Neoplasm,
pubmed-meshheading:308102-Antigens, Neoplasm,
pubmed-meshheading:308102-B-Lymphocytes,
pubmed-meshheading:308102-Cell Line,
pubmed-meshheading:308102-Cell Membrane,
pubmed-meshheading:308102-Child,
pubmed-meshheading:308102-Cytotoxicity, Immunologic,
pubmed-meshheading:308102-Humans,
pubmed-meshheading:308102-Leukemia, Experimental,
pubmed-meshheading:308102-Leukemia, Lymphoid,
pubmed-meshheading:308102-Leukemia, Myeloid, Acute,
pubmed-meshheading:308102-Molecular Weight,
pubmed-meshheading:308102-Rabbits,
pubmed-meshheading:308102-T-Lymphocytes
|
pubmed:year |
1978
|
pubmed:articleTitle |
Acute lymphocytic leukemia-associated cell membrane antigen.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|